Dimensional Fund Advisors
TNYA icon

Dimensional Fund Advisors’s Tenaya Therapeutics TNYA Stock Holding History

Dimensional Fund Advisors’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.9K Sell
64,904
-5,574
-8% -$4.11K ﹤0.01% 3179
2025
Q4 		$50.1K Sell
70,478
-2,930
-4% -$3.98K ﹤0.01% 3210
2025
Q3 		$119K Hold
73,408
– – ﹤0.01% 3169
2025
Q2 		$44.9K Hold
73,408
– – ﹤0.01% 3241
2025
Q1 		$41.8K Sell
73,408
-24,573
-25% -$24.2K ﹤0.01% 3269
2024
Q4 		$140K Sell
97,981
-16,251
-14% -$36.4K ﹤0.01% 3200
2024
Q3 		$220K Buy
114,232
+12,206
+12% +$34.5K ﹤0.01% 3155
2024
Q2 		$316K Buy
102,026
+30,446
+43% +$126K ﹤0.01% 3103
2024
Q1 		$374K Sell
71,580
-30,455
-30% -$146K ﹤0.01% 3095
2023
Q4 		$331K Sell
102,035
-72,730
-42% -$157K ﹤0.01% 3113
2023
Q3 		$446K Buy
174,765
+109,145
+166% +$457K ﹤0.01% 3066
2023
Q2 		$385K Buy
65,620
+4,847
+8% +$28.2K ﹤0.01% 3119
2023
Q1 		$173K Buy
+60,773
New +$171K ﹤0.01% 3232

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's TNYA Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Tenaya Therapeutics (TNYA) stake by 7.9% in Q1 2026, selling an estimated $4.11K and leaving 64,904 shares worth $44.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3179.

Dimensional Fund Advisors first reported a position in TNYA in Q1 2023 and has held it in 13 quarters since. The position peaked at $446K in Q3 2023. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Dimensional Fund Advisors held 64,904 shares of Tenaya Therapeutics worth $44.9K as of Q1 2026.
  • Dimensional Fund Advisors sold 5,574 Tenaya Therapeutics shares in Q1 2026, an estimated $4.11K.
  • Tenaya Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3179 holding.
  • Dimensional Fund Advisors first reported a position in Tenaya Therapeutics in Q1 2023 and has held it in 13 quarters since.
  • Dimensional Fund Advisors's Tenaya Therapeutics position peaked at $446K in Q3 2023.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.